Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 39

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 39
---
      |     | NeoGenomics, Inc.                       |     | Voyager Therapeutics, Inc.      |
| Guardant Health, Inc.       |     | Pacific Biosciences of California, Inc. |     |                                 |

29

Elements of Executive Compensation Base Salary In the first quarter of 2024, the compensation and human capital committee conducted its annual review of the base salaries of our named executive officers. Consistent with our ongoing focus on reducing operating expenses, not all named executive officers received an increase in base salary for 2024. Mr. Robins and Dr. Robins each received 3% increases, and Mr. Piskel’s base salary was increased 4% prior to his promotion to Chief Financial Officer and again increased in connection with his elevation to Chief Financial Officer. Annual Incentives We provide annual incentives to create a direct correlation between the executive’s role and responsibilities and the ability to earn variable pay. Achievement of these goals are then evaluated alongside individual goals for each executive. We believe that the financial metrics in our incentive program provide ample liquidity to efficiently fund our progression to profitability in the MRD business, while our business goals ensure diligent execution against critical milestones toward expansion of our product base and pipeline. The compensation and human capital committee believes that the balance between quantifiable, objective measures and milestone strategic priorities best motivates our executives’ performance and allows for a holistic assessment of performance at year end. That said, the committee also believes that placing a majority weighting on quantifiable, objective measures is paramount and reflective of the importance of continued momentum towards long-term profitability and operating efficiency. Incentive Compensation and 2024 Goals Achievement The compensation and human capital committee determines the achievement level for each of the goals and the overall payout, not to exceed 125% of target except in extraordinary circumstances, based on the weighted achievement of the goals. Mr. Robins’ annual incentive is weighted 100% to corporate goals, and all other named executive officer annual incentives are weighted 75% to corporate goals and 25% to individual performance.

| Goal                             
 Category                         |     | Goals                              |     | Performance                      |     | Outcome |                 |     | Payout |     |   |
| Financial (60%)                  |     | Revenue – MRD only (30%)           |     | Quantitative Assessment(1)       |     |         | Achieved        |     |        |  30 | % |
|                                  |     | Cash Burn (15%)(2)                 |     | Quant